Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 4
Submit an article Journal homepage
44
Views
1
CrossRef citations to date
0
Altmetric
Miscellaneous

Over 5 years of darbepoetin alfa: two case histories

Alison J Roche Renal Unit, King’s College Hospital (Dulwich), East Dulwich Grove, London, SE22 8PT, UK. [email protected]
&
Iain C Macdougall Renal Unit, King’s College Hospital (Dulwich), East Dulwich Grove, London, SE22 8PT, UK. [email protected]
Pages 951-954 | Published online: 02 Mar 2005

Bibliography

  • LEVIN A: Anaemia in the patient with renal insufficiency: documenting the impact and reviewing treatment strategies. Nephrol. Dial. Transplant. (1999) 14:292–295.
  • European Best Practice Guidelines for the Management of Anaemia in Patients With Chronic Renal Failure Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. Nephrol.Transplant. (1999) 14\(Suppl. 5):1–50.
  • MACDOUGALL IC, GRAY SJ, ELSTON 0 et al: Pharmacokinetics of novel erythropoiesis stimulating protein compared with epoetin alfa in dialysis patients. I Am. Soc. Nephrol. (1999) 10:2392–2395.
  • MACDOUGALL IC: Novel erythropoiesisstimulating protein. Semin. Nephrol. (2000) 20:375–381.
  • MACDOUGALL IC: Optimizing erythropoietin therapy. Curt: Opin. Hematol (1999) 6:121–126.
  • LOCATELLI F: Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo). Nephrol. Transplant. (2003) 18:362–369.
  • VANRENTERGHEM Y, BARÁNY P, MANN J et al.: Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney mt. (2002) 62:2167–2175.
  • MACDOUGALL IC, MATCHAM J, GRAY SJ, on behalf of the NESP 960245/246 STUDY GROUP: Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis. Nephrol. Dial. Transplant. (2003) 18:576–581.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.